Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics of sustained-release dexamphetamine tablets and dried blood spot validation
NL-OMON44699Active, not recruiting
- Sponsor
- Di-AcetylM
- Start
- Oct 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of dextroamphetamine in substance use disorder (SUD) and cocaine use disorder (CUD), sponsored by Di-AcetylM. Primary endpoints: Pharmacokinetic properties of the sustained-release dexamphetamine formulation and Validation of dexamphetamine measurement in dried blood spots. Started Oct 2016; status: active, not recruiting.
02
Drugs
dextroamphetamine
03
Conditions
substance use disorder (SUD)cocaine use disorder (CUD)
Beyond the preview
Go deeper on NL-OMON44699.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON44699.